Skip to content
healthcare.dev

Ertapenem

NDC 51810-504, ertapenem sodium, injection, powder, lyophilized, for solution, from Qilu Antibiotics Pharmaceutical Co., Ltd..

Product NDC
51810-504
Status
Listed
Labeler
Qilu Antibiotics Pharmaceutical Co., Ltd.
Dosage form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route
INTRAMUSCULAR, INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA218067
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/51810-504 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ERTAPENEM SODIUM1 g/1

Pharmacologic classes

Carbapenems [CS]; Penem Antibacterial [EPC]

Package NDCNDC-11Package
51810-504-025181005040210 VIAL, SINGLE-DOSE in 1 CARTON (51810-504-02) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (51810-504-01)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/44496f7c-8407-4765-9cd6-1daa619a6db6

Use it

Look up 51810-504 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/51810-504 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 51810-504. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.